Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1141320200350010038
Kosin Medical Journal
2020 Volume.35 No. 1 p.38 ~ p.46
Clinical Usefulness of Contrast-Enhanced Computed Tomography in Patients with Non-Obstructive Acute Pyleonephritis
Sun In-O

Lim Ji-Hye
Oh Ju-Hwan
Cho A-Young
Kim Beum-Jin
Lee Kwang-Young
Lee Mi-Sook
Abstract
Objectives: The aim of this study is to investigate the clinical utility of contrast-enhanced computed tomography (CECT) in patient with non-obstrcutive acute pyelonephritis (APN).

Methods: From 2007 to 2013, 537 APN patients who underwent a CE-CT scan within 24 hours after hospital admission were enrolled. We divided these patients into greater (50% or greater involvment, n = 143) and lesser (less than 50% involvement, n = 394) groups based on renal parenchymal involvement in CE-CT examination. We compared clinical characteristics between two groups and analyzed the clinical value of CE-CT scan as a reliable marker for predicting clinical severity and disease course in patient with non-obstructive APN.

Results: The mean estimated glomerular filtration rate was 70.6 ¡¾ 25.5 mL/min/1.73m2. Compared with patients in lesser group, the patients in greater group had lower serum albumin levels (3.5 ¡¾ 0.5 vs 3.8 ¡¾ 0.6, P< 0.01) and longer hosptal stay (10.1 ¡¾ 4.7 vs 8.8 ¡¾ 4.5, P< 0.05). In addition, acute kidney injury (AKI) (23.1% vs 11.4%, P< 0.005) and bacteremia (36.4% vs 26.8%, P= 0.02) were frequently developed in greater group, respectively. The overall incidence of AKI was 14.8% based on RIFLE criteria. In a multivariate logistic regression analysis for predciting AKI, age, presence of diabetes mellitus and the presence of renal parenchymal involvement of greater than 50% in CE-CT were significant predictors of AKI.

Conclusions: The CE-CT scan could be useful to predict the clinical severity and course in non-obstructive APN patients with preserved renal function.
KEYWORD
Acute kidney injury, Computed tomography, Pyelonephritis
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed